Ixekizumab Subcutaneous and Plasma-Lyte 56 and Dextrose
Determining the interaction of Ixekizumab Subcutaneous and Plasma-Lyte 56 and Dextrose and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ixekizumab
Brand name: Taltz Autoinjector, Taltz Prefilled Syringe
Synonyms: Ixekizumab
Generic Name: lvp solution with potassium
Brand name:
Synonyms: Dextrose and Electrolyte No 48
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ixekizumab Subcutaneous-Platinol
- Ixekizumab Subcutaneous-Platinol-AQ
- Ixekizumab Subcutaneous-Plavix
- Ixekizumab Subcutaneous-Plazomicin
- Ixekizumab Subcutaneous-Plazomicin Intravenous
- Ixekizumab Subcutaneous-Plazomicin Sulfate
- Plasma-Lyte 56 and Dextrose-Ixempra
- Plasma-Lyte 56 and Dextrose-Ixempra Kit
- Plasma-Lyte 56 and Dextrose-Ixiaro
- Plasma-Lyte 56 and Dextrose-Ixifi Intravenous
- Plasma-Lyte 56 and Dextrose-Ixinity
- Plasma-Lyte 56 and Dextrose-Ixinity Intravenous